Search research articles
Contact Us
Filters
Showing results (71-80 of 87) with videos related to
Page
of 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2016
Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA
Jeffrey C Thompson, Stephanie S Yee, Andrea B Troxel, et al.
JTO Clinical and Research Reports
|
April 8, 2022
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study
Jeffrey C Thompson, Charu Aggarwal, Janeline Wong, et al.
JCO Oncology Practice
|
July 3, 2024
Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From a Prospective Clinical Trial
Melina E Marmarelis, Dylan G Scholes, Tara L McWilliams, et al.
Pigment Cell & Melanoma Research
|
August 9, 2017
Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma
Tara C Gangadhar, Samantha L Savitch, Stephanie S Yee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2020
Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer
Charu Aggarwal, Jeffrey C Thompson, Austin L Chien, et al.
JAMA Oncology
|
October 17, 2018
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer
Charu Aggarwal, Jeffrey C Thompson, Taylor A Black, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2025
Corticosteroid-Dependent Association between Prognostic Peripheral Blood Cell-Free DNA Levels and Neutrophil-Mediated NETosis in Patients with Glioblastoma
Jacob E Till, Nicholas J Seewald, Zachariya Yazdani, et al.
Clinical and Translational Medicine
|
January 19, 2026
Plasma cell-free DNA markers predict occult metastases in patients with resectable pancreatic ductal adenocarcinoma
Jacob E Till, Ofer Gal-Rosenberg, Sophia G Giliberto, et al.
Breast Cancer Research and Treatment
|
January 23, 2023
Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study
Mark Jesus M Magbanua, Laura van 't Veer, Amy S Clark, et al.
The Lancet. Oncology
|
January 2, 2021
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study
Mark H O'Hara, Eileen M O'Reilly, Gauri Varadhachary, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 87) with videos related to
Sort By:
Page
of 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2016
Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA
Jeffrey C Thompson, Stephanie S Yee, Andrea B Troxel, et al.
JTO Clinical and Research Reports
|
April 8, 2022
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study
Jeffrey C Thompson, Charu Aggarwal, Janeline Wong, et al.
JCO Oncology Practice
|
July 3, 2024
Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From a Prospective Clinical Trial
Melina E Marmarelis, Dylan G Scholes, Tara L McWilliams, et al.
Pigment Cell & Melanoma Research
|
August 9, 2017
Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma
Tara C Gangadhar, Samantha L Savitch, Stephanie S Yee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2020
Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer
Charu Aggarwal, Jeffrey C Thompson, Austin L Chien, et al.
JAMA Oncology
|
October 17, 2018
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer
Charu Aggarwal, Jeffrey C Thompson, Taylor A Black, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2025
Corticosteroid-Dependent Association between Prognostic Peripheral Blood Cell-Free DNA Levels and Neutrophil-Mediated NETosis in Patients with Glioblastoma
Jacob E Till, Nicholas J Seewald, Zachariya Yazdani, et al.
Clinical and Translational Medicine
|
January 19, 2026
Plasma cell-free DNA markers predict occult metastases in patients with resectable pancreatic ductal adenocarcinoma
Jacob E Till, Ofer Gal-Rosenberg, Sophia G Giliberto, et al.
Breast Cancer Research and Treatment
|
January 23, 2023
Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study
Mark Jesus M Magbanua, Laura van 't Veer, Amy S Clark, et al.
The Lancet. Oncology
|
January 2, 2021
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study
Mark H O'Hara, Eileen M O'Reilly, Gauri Varadhachary, et al.
Page
of 9